Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biolase, Inc. - Common Stock (NQ:BIOL)

0.1290 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biolase, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
BIOLASE Voluntarily Initiates Chapter 11 Proceedings
Via ACCESSWIRE
BIOL Stock Earnings: Biolase Misses EPS, Misses Revenue for Q2 2024
BIOL stock results show that Biolase missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen
Via ACCESSWIRE
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability
Via ACCESSWIRE
Recap: Biolase Q4 Earnings
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
BIOLASE Announces Delisting from Nasdaq
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning! 
Via InvestorPlace
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
BIOL Stock Earnings: Biolase Misses EPS, Beats Revenue for Q1 2024
BIOL stock results show that Biolase missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
BIOLASE to Report First Quarter 2024 Results on May 13, 2024
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points. The Dow traded down 0.54% to 39,565.50 while the NASDAQ rose 0.04% to 16,408.74. The S&P 500 also... 
Via Benzinga
Topics Stocks
Why BIOLASE Shares Are Surging Friday
BIOLASE, Inc. shares rise 31% after better-than-expected FY23 EPS results, strong revenue growth expected in 2024 due to increased laser adoption. 
Via Benzinga
US Stocks Edge Lower; FedEx Posts Upbeat Earnings
U.S. stocks traded slightly lower this morning. Following the market opening Friday, the Dow traded down 0.06% to 39,758.88 while the NASDAQ fell 0.10% to 16,385.60. The S&P 500 also fell, dropping,... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion 
Via Benzinga
BIOL Stock Earnings: Biolase Beats EPS, Misses Revenue for Q4 2023
BIOL stock results show that Biolase beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024
Via ACCESSWIRE
Earnings Scheduled For March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.